Recent weak economic data, disappointing earnings reports, and turmoil in the financial sector have raised recessionary pressures of late, dragging down equities. As the stock market is expected to remain under immense pressure, investors should avoid high-risk stocks Roku (ROKU), Bitfarms (BITF), and CleanSpark (CLSK) this month, with weak growth prospects. Read on…. The latest ..
Tag : Stocks
The cloud computing market is growing amid organizations investing in digitization and emerging technologies. Given the solid prospects of the industry, investors could consider adding fundamentally sound cloud stocks, ServiceNow (NOW) and Splunk (SPLK), which seem poised to see high demand. These stocks are Buy-rated in our proprietary rating system. Read on. The software industry ..
A better way to play for a probabilistic pullback in MSFT with cheap puts. Microsoft (MSFT) is one of two U.S companies sporting a market cap over $2 trillion. MSFT stock has rallied over 30% in the past few months after making a recent low near $220 on January 6. The recent red-hot rally is ..
There is a lot of bearish energy out there right now. Even the Fed seems to be calling for a recession… and the experts who aren’t worried about a recession are worried about stagflation. (For anyone who is a few years removed from Econ 101, that’s the one where we have sticky high inflation AND ..
The future outlook for the stock market (SPY) is getting more confusing…not less. Why is that? What does that mean for stocks in the weeks ahead? And what is the best trading plan to stay ahead of the pack? 40 year investment veteran Steve Reitmeister shares his views in the commentary below including his top ..
Since the high inflation is leading to rising healthcare spending, it could be wise to sell fundamentally weak medical stocks, Pacific Biosciences (PACB), DermTech (DMTK), and Genetic Technologies (GENE), before things get even uglier. Continue reading…. While investors anticipate the Fed to turn dovish in light of the banking crisis, rising oil prices might lead ..
The biotech sector is witnessing the headwinds from the banking crisis, layoffs, and the Inflation Reduction Act. So, fundamentally weak biotech stocks Ginkgo Bioworks Holdings (DNA) and Novavax (NVAX) might be best avoided. Read on. The biotech industry thrived during the pandemic. However, despite robust demand, the industry is currently pressured by macroeconomic headwinds and ..
While I think the bulls have made major strides in the first quarter, I think it’s too early to say we’re completely out of the woods. So I thought this would be the perfect time to look back at the Q1 of 2023 and review the factors that influence the S& 500 and what we ..
There are finally cracks in the previously resilient employment foundation of the economy. This is leading more investors to become bearish on the stock market. That is hard to see through the lens of the S&P 500 (SPY). However it becomes MUCH more apparent when you review these 3 charts. Read on below for the ..
The hype surrounding generative artificial intelligence has been the rising tide that has lifted many boats, including C3.ai (AI), which has waded into a serious controversy and could find itself stranded once the tide goes out. Read on. The stock of C3.ai, Inc. (AI), which has been riding the hype surrounding generative artificial intelligence after ..
